nodes	percent_of_prediction	percent_of_DWPC	metapath
Pioglitazone—SLCO1B3—Paclitaxel—ovarian cancer	0.223	0.331	CbGbCtD
Pioglitazone—SLCO1B3—Docetaxel—ovarian cancer	0.161	0.239	CbGbCtD
Pioglitazone—CYP2C8—Paclitaxel—ovarian cancer	0.055	0.0816	CbGbCtD
Pioglitazone—CYP2D6—Vinorelbine—ovarian cancer	0.0499	0.0741	CbGbCtD
Pioglitazone—CYP3A4—Topotecan—ovarian cancer	0.0451	0.0669	CbGbCtD
Pioglitazone—CYP2C9—Paclitaxel—ovarian cancer	0.0384	0.0569	CbGbCtD
Pioglitazone—CYP3A4—Vinorelbine—ovarian cancer	0.0318	0.0471	CbGbCtD
Pioglitazone—CYP3A4—Paclitaxel—ovarian cancer	0.0223	0.0331	CbGbCtD
Pioglitazone—CYP2D6—Doxorubicin—ovarian cancer	0.0189	0.0281	CbGbCtD
Pioglitazone—CYP3A4—Docetaxel—ovarian cancer	0.0161	0.0239	CbGbCtD
Pioglitazone—CYP3A4—Doxorubicin—ovarian cancer	0.012	0.0178	CbGbCtD
Pioglitazone—PPARG—Irinotecan—Topotecan—ovarian cancer	0.00752	1	CbGdCrCtD
Pioglitazone—PTGS1—oviduct—ovarian cancer	0.00207	0.107	CbGeAlD
Pioglitazone—SLCO1B3—vagina—ovarian cancer	0.00131	0.0677	CbGeAlD
Pioglitazone—PPARG—embryo—ovarian cancer	0.00119	0.0616	CbGeAlD
Pioglitazone—PPARG—epithelium—ovarian cancer	0.000972	0.0503	CbGeAlD
Pioglitazone—PPARG—decidua—ovarian cancer	0.000918	0.0475	CbGeAlD
Pioglitazone—SLCO1B1—female reproductive system—ovarian cancer	0.000837	0.0433	CbGeAlD
Pioglitazone—PPARG—uterus—ovarian cancer	0.000803	0.0415	CbGeAlD
Pioglitazone—PPARG—female reproductive system—ovarian cancer	0.000722	0.0373	CbGeAlD
Pioglitazone—PPARG—bone marrow—ovarian cancer	0.000682	0.0353	CbGeAlD
Pioglitazone—PPARG—female gonad—ovarian cancer	0.000657	0.034	CbGeAlD
Pioglitazone—PPARG—vagina—ovarian cancer	0.000653	0.0338	CbGeAlD
Pioglitazone—PPARG—testis—ovarian cancer	0.000583	0.0301	CbGeAlD
Pioglitazone—CYP2C8—endometrium—ovarian cancer	0.000575	0.0297	CbGeAlD
Pioglitazone—Pharyngitis—Paclitaxel—ovarian cancer	0.000535	0.00214	CcSEcCtD
Pioglitazone—Urinary tract disorder—Paclitaxel—ovarian cancer	0.000532	0.00212	CcSEcCtD
Pioglitazone—Oedema peripheral—Paclitaxel—ovarian cancer	0.000531	0.00212	CcSEcCtD
Pioglitazone—Connective tissue disorder—Paclitaxel—ovarian cancer	0.000529	0.00211	CcSEcCtD
Pioglitazone—Urticaria—Topotecan—ovarian cancer	0.000529	0.00211	CcSEcCtD
Pioglitazone—Urethral disorder—Paclitaxel—ovarian cancer	0.000528	0.00211	CcSEcCtD
Pioglitazone—Cramps of lower extremities—Doxorubicin—ovarian cancer	0.000521	0.00208	CcSEcCtD
Pioglitazone—PTGS1—epithelium—ovarian cancer	0.00052	0.0269	CbGeAlD
Pioglitazone—Weight increased—Docetaxel—ovarian cancer	0.000519	0.00207	CcSEcCtD
Pioglitazone—Visual impairment—Paclitaxel—ovarian cancer	0.000519	0.00207	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Vinorelbine—ovarian cancer	0.000519	0.00207	CcSEcCtD
Pioglitazone—Urticaria—Melphalan—ovarian cancer	0.000518	0.00207	CcSEcCtD
Pioglitazone—Weight decreased—Docetaxel—ovarian cancer	0.000516	0.00206	CcSEcCtD
Pioglitazone—PTGS1—uterine cervix—ovarian cancer	0.000515	0.0266	CbGeAlD
Pioglitazone—Neoplasm—Doxorubicin—ovarian cancer	0.000513	0.00205	CcSEcCtD
Pioglitazone—Diabetes mellitus—Epirubicin—ovarian cancer	0.000512	0.00204	CcSEcCtD
Pioglitazone—Diarrhoea—Chlorambucil—ovarian cancer	0.000511	0.00204	CcSEcCtD
Pioglitazone—Infestation NOS—Docetaxel—ovarian cancer	0.000509	0.00203	CcSEcCtD
Pioglitazone—Infestation—Docetaxel—ovarian cancer	0.000509	0.00203	CcSEcCtD
Pioglitazone—Dyspnoea—Vinorelbine—ovarian cancer	0.000507	0.00203	CcSEcCtD
Pioglitazone—Pulmonary oedema—Doxorubicin—ovarian cancer	0.000505	0.00202	CcSEcCtD
Pioglitazone—Eye disorder—Paclitaxel—ovarian cancer	0.000504	0.00201	CcSEcCtD
Pioglitazone—Acute coronary syndrome—Docetaxel—ovarian cancer	0.000501	0.002	CcSEcCtD
Pioglitazone—Cardiac disorder—Paclitaxel—ovarian cancer	0.0005	0.002	CcSEcCtD
Pioglitazone—Myocardial infarction—Docetaxel—ovarian cancer	0.000499	0.00199	CcSEcCtD
Pioglitazone—Hepatic failure—Epirubicin—ovarian cancer	0.000495	0.00198	CcSEcCtD
Pioglitazone—Abnormal vision—Doxorubicin—ovarian cancer	0.000495	0.00198	CcSEcCtD
Pioglitazone—CYP2C19—vagina—ovarian cancer	0.000493	0.0255	CbGeAlD
Pioglitazone—Gastrointestinal disorder—Vinorelbine—ovarian cancer	0.000491	0.00196	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Epirubicin—ovarian cancer	0.000491	0.00196	CcSEcCtD
Pioglitazone—Fatigue—Vinorelbine—ovarian cancer	0.000491	0.00196	CcSEcCtD
Pioglitazone—Hypersensitivity—Topotecan—ovarian cancer	0.00049	0.00196	CcSEcCtD
Pioglitazone—Immune system disorder—Paclitaxel—ovarian cancer	0.000487	0.00194	CcSEcCtD
Pioglitazone—Mediastinal disorder—Paclitaxel—ovarian cancer	0.000486	0.00194	CcSEcCtD
Pioglitazone—Hypersensitivity—Melphalan—ovarian cancer	0.00048	0.00192	CcSEcCtD
Pioglitazone—Asthenia—Topotecan—ovarian cancer	0.000477	0.00191	CcSEcCtD
Pioglitazone—CYP2C8—female reproductive system—ovarian cancer	0.000476	0.0246	CbGeAlD
Pioglitazone—Increased appetite—Epirubicin—ovarian cancer	0.000474	0.00189	CcSEcCtD
Pioglitazone—Diabetes mellitus—Doxorubicin—ovarian cancer	0.000474	0.00189	CcSEcCtD
Pioglitazone—Malnutrition—Paclitaxel—ovarian cancer	0.000469	0.00187	CcSEcCtD
Pioglitazone—Feeling abnormal—Vinorelbine—ovarian cancer	0.000469	0.00187	CcSEcCtD
Pioglitazone—Asthenia—Melphalan—ovarian cancer	0.000467	0.00187	CcSEcCtD
Pioglitazone—PTGS1—endometrium—ovarian cancer	0.000466	0.0241	CbGeAlD
Pioglitazone—Flatulence—Paclitaxel—ovarian cancer	0.000462	0.00185	CcSEcCtD
Pioglitazone—Hepatic failure—Doxorubicin—ovarian cancer	0.000458	0.00183	CcSEcCtD
Pioglitazone—Hepatitis—Docetaxel—ovarian cancer	0.000457	0.00182	CcSEcCtD
Pioglitazone—Hypoglycaemia—Epirubicin—ovarian cancer	0.000456	0.00182	CcSEcCtD
Pioglitazone—Cardiac failure—Epirubicin—ovarian cancer	0.000456	0.00182	CcSEcCtD
Pioglitazone—Diarrhoea—Topotecan—ovarian cancer	0.000455	0.00182	CcSEcCtD
Pioglitazone—Hypoaesthesia—Docetaxel—ovarian cancer	0.000454	0.00181	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Epirubicin—ovarian cancer	0.000454	0.00181	CcSEcCtD
Pioglitazone—Cardiac failure congestive—Doxorubicin—ovarian cancer	0.000454	0.00181	CcSEcCtD
Pioglitazone—Back pain—Paclitaxel—ovarian cancer	0.000454	0.00181	CcSEcCtD
Pioglitazone—Pharyngitis—Docetaxel—ovarian cancer	0.000453	0.00181	CcSEcCtD
Pioglitazone—Urticaria—Vinorelbine—ovarian cancer	0.000452	0.00181	CcSEcCtD
Pioglitazone—Urinary tract disorder—Docetaxel—ovarian cancer	0.000451	0.0018	CcSEcCtD
Pioglitazone—Muscle spasms—Paclitaxel—ovarian cancer	0.000451	0.0018	CcSEcCtD
Pioglitazone—Oedema peripheral—Docetaxel—ovarian cancer	0.00045	0.0018	CcSEcCtD
Pioglitazone—Connective tissue disorder—Docetaxel—ovarian cancer	0.000449	0.00179	CcSEcCtD
Pioglitazone—Urethral disorder—Docetaxel—ovarian cancer	0.000448	0.00179	CcSEcCtD
Pioglitazone—Diarrhoea—Melphalan—ovarian cancer	0.000446	0.00178	CcSEcCtD
Pioglitazone—Pain in extremity—Epirubicin—ovarian cancer	0.000445	0.00178	CcSEcCtD
Pioglitazone—Visual impairment—Docetaxel—ovarian cancer	0.00044	0.00176	CcSEcCtD
Pioglitazone—Dizziness—Topotecan—ovarian cancer	0.00044	0.00176	CcSEcCtD
Pioglitazone—Increased appetite—Doxorubicin—ovarian cancer	0.000439	0.00175	CcSEcCtD
Pioglitazone—Ill-defined disorder—Paclitaxel—ovarian cancer	0.000435	0.00174	CcSEcCtD
Pioglitazone—Anaemia—Paclitaxel—ovarian cancer	0.000434	0.00173	CcSEcCtD
Pioglitazone—CYP2C8—vagina—ovarian cancer	0.00043	0.0223	CbGeAlD
Pioglitazone—PTGS1—uterus—ovarian cancer	0.000429	0.0222	CbGeAlD
Pioglitazone—Angioedema—Paclitaxel—ovarian cancer	0.000429	0.00171	CcSEcCtD
Pioglitazone—Eye disorder—Docetaxel—ovarian cancer	0.000427	0.0017	CcSEcCtD
Pioglitazone—Cardiac disorder—Docetaxel—ovarian cancer	0.000424	0.00169	CcSEcCtD
Pioglitazone—Malaise—Paclitaxel—ovarian cancer	0.000423	0.00169	CcSEcCtD
Pioglitazone—CYP2C9—female reproductive system—ovarian cancer	0.000423	0.0219	CbGeAlD
Pioglitazone—PPARG—lymph node—ovarian cancer	0.000422	0.0218	CbGeAlD
Pioglitazone—Cardiac failure—Doxorubicin—ovarian cancer	0.000422	0.00169	CcSEcCtD
Pioglitazone—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000422	0.00169	CcSEcCtD
Pioglitazone—Vertigo—Paclitaxel—ovarian cancer	0.000421	0.00168	CcSEcCtD
Pioglitazone—Cerebrovascular accident—Doxorubicin—ovarian cancer	0.00042	0.00168	CcSEcCtD
Pioglitazone—Hypersensitivity—Vinorelbine—ovarian cancer	0.000419	0.00167	CcSEcCtD
Pioglitazone—Headache—Topotecan—ovarian cancer	0.000417	0.00166	CcSEcCtD
Pioglitazone—Immune system disorder—Docetaxel—ovarian cancer	0.000413	0.00165	CcSEcCtD
Pioglitazone—Pain in extremity—Doxorubicin—ovarian cancer	0.000412	0.00165	CcSEcCtD
Pioglitazone—Mediastinal disorder—Docetaxel—ovarian cancer	0.000412	0.00164	CcSEcCtD
Pioglitazone—Liver function test abnormal—Epirubicin—ovarian cancer	0.000411	0.00164	CcSEcCtD
Pioglitazone—Asthenia—Vinorelbine—ovarian cancer	0.000408	0.00163	CcSEcCtD
Pioglitazone—Abdominal pain upper—Epirubicin—ovarian cancer	0.000407	0.00162	CcSEcCtD
Pioglitazone—Hypertension—Paclitaxel—ovarian cancer	0.000405	0.00162	CcSEcCtD
Pioglitazone—Breast disorder—Epirubicin—ovarian cancer	0.000402	0.00161	CcSEcCtD
Pioglitazone—Chest pain—Paclitaxel—ovarian cancer	0.000399	0.00159	CcSEcCtD
Pioglitazone—Myalgia—Paclitaxel—ovarian cancer	0.000399	0.00159	CcSEcCtD
Pioglitazone—Arthralgia—Paclitaxel—ovarian cancer	0.000399	0.00159	CcSEcCtD
Pioglitazone—Malnutrition—Docetaxel—ovarian cancer	0.000398	0.00159	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000397	0.00158	CcSEcCtD
Pioglitazone—Discomfort—Paclitaxel—ovarian cancer	0.000395	0.00158	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Epirubicin—ovarian cancer	0.000393	0.00157	CcSEcCtD
Pioglitazone—Diarrhoea—Vinorelbine—ovarian cancer	0.000389	0.00156	CcSEcCtD
Pioglitazone—PTGS1—female reproductive system—ovarian cancer	0.000386	0.02	CbGeAlD
Pioglitazone—Influenza—Epirubicin—ovarian cancer	0.000385	0.00154	CcSEcCtD
Pioglitazone—Back pain—Docetaxel—ovarian cancer	0.000385	0.00154	CcSEcCtD
Pioglitazone—CYP2C8—testis—ovarian cancer	0.000384	0.0199	CbGeAlD
Pioglitazone—Oedema—Paclitaxel—ovarian cancer	0.000383	0.00153	CcSEcCtD
Pioglitazone—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000383	0.00153	CcSEcCtD
Pioglitazone—Muscle spasms—Docetaxel—ovarian cancer	0.000382	0.00153	CcSEcCtD
Pioglitazone—Liver function test abnormal—Doxorubicin—ovarian cancer	0.00038	0.00152	CcSEcCtD
Pioglitazone—Infection—Paclitaxel—ovarian cancer	0.00038	0.00152	CcSEcCtD
Pioglitazone—Dizziness—Vinorelbine—ovarian cancer	0.000376	0.0015	CcSEcCtD
Pioglitazone—Abdominal pain upper—Doxorubicin—ovarian cancer	0.000376	0.0015	CcSEcCtD
Pioglitazone—Nervous system disorder—Paclitaxel—ovarian cancer	0.000375	0.0015	CcSEcCtD
Pioglitazone—Angina pectoris—Epirubicin—ovarian cancer	0.000375	0.0015	CcSEcCtD
Pioglitazone—Breast disorder—Doxorubicin—ovarian cancer	0.000372	0.00149	CcSEcCtD
Pioglitazone—Skin disorder—Paclitaxel—ovarian cancer	0.000372	0.00148	CcSEcCtD
Pioglitazone—Bronchitis—Epirubicin—ovarian cancer	0.00037	0.00148	CcSEcCtD
Pioglitazone—Hyperhidrosis—Paclitaxel—ovarian cancer	0.00037	0.00148	CcSEcCtD
Pioglitazone—Anaemia—Docetaxel—ovarian cancer	0.000367	0.00147	CcSEcCtD
Pioglitazone—Alanine aminotransferase increased—Doxorubicin—ovarian cancer	0.000363	0.00145	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Epirubicin—ovarian cancer	0.000358	0.00143	CcSEcCtD
Pioglitazone—Headache—Vinorelbine—ovarian cancer	0.000357	0.00142	CcSEcCtD
Pioglitazone—Influenza—Doxorubicin—ovarian cancer	0.000356	0.00142	CcSEcCtD
Pioglitazone—PTGS1—female gonad—ovarian cancer	0.000351	0.0182	CbGeAlD
Pioglitazone—Weight increased—Epirubicin—ovarian cancer	0.00035	0.0014	CcSEcCtD
Pioglitazone—PTGS1—vagina—ovarian cancer	0.000349	0.0181	CbGeAlD
Pioglitazone—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000349	0.00139	CcSEcCtD
Pioglitazone—Weight decreased—Epirubicin—ovarian cancer	0.000348	0.00139	CcSEcCtD
Pioglitazone—Hyperglycaemia—Epirubicin—ovarian cancer	0.000347	0.00139	CcSEcCtD
Pioglitazone—Angina pectoris—Doxorubicin—ovarian cancer	0.000347	0.00139	CcSEcCtD
Pioglitazone—Insomnia—Paclitaxel—ovarian cancer	0.000346	0.00138	CcSEcCtD
Pioglitazone—Hypertension—Docetaxel—ovarian cancer	0.000343	0.00137	CcSEcCtD
Pioglitazone—Infestation NOS—Epirubicin—ovarian cancer	0.000343	0.00137	CcSEcCtD
Pioglitazone—Infestation—Epirubicin—ovarian cancer	0.000343	0.00137	CcSEcCtD
Pioglitazone—Bronchitis—Doxorubicin—ovarian cancer	0.000342	0.00137	CcSEcCtD
Pioglitazone—Dyspnoea—Paclitaxel—ovarian cancer	0.000341	0.00136	CcSEcCtD
Pioglitazone—Chest pain—Docetaxel—ovarian cancer	0.000338	0.00135	CcSEcCtD
Pioglitazone—Myalgia—Docetaxel—ovarian cancer	0.000338	0.00135	CcSEcCtD
Pioglitazone—Arthralgia—Docetaxel—ovarian cancer	0.000338	0.00135	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000336	0.00134	CcSEcCtD
Pioglitazone—Urinary tract infection—Epirubicin—ovarian cancer	0.000334	0.00133	CcSEcCtD
Pioglitazone—Upper respiratory tract infection—Doxorubicin—ovarian cancer	0.000331	0.00132	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.00033	0.00132	CcSEcCtD
Pioglitazone—Fatigue—Paclitaxel—ovarian cancer	0.00033	0.00132	CcSEcCtD
Pioglitazone—Sweating—Epirubicin—ovarian cancer	0.000329	0.00131	CcSEcCtD
Pioglitazone—Haematuria—Epirubicin—ovarian cancer	0.000327	0.00131	CcSEcCtD
Pioglitazone—Anaphylactic shock—Docetaxel—ovarian cancer	0.000324	0.0013	CcSEcCtD
Pioglitazone—Oedema—Docetaxel—ovarian cancer	0.000324	0.0013	CcSEcCtD
Pioglitazone—Weight increased—Doxorubicin—ovarian cancer	0.000324	0.00129	CcSEcCtD
Pioglitazone—CYP3A4—female reproductive system—ovarian cancer	0.000322	0.0167	CbGeAlD
Pioglitazone—Infection—Docetaxel—ovarian cancer	0.000322	0.00129	CcSEcCtD
Pioglitazone—Weight decreased—Doxorubicin—ovarian cancer	0.000322	0.00129	CcSEcCtD
Pioglitazone—Sinusitis—Epirubicin—ovarian cancer	0.000322	0.00129	CcSEcCtD
Pioglitazone—Hyperglycaemia—Doxorubicin—ovarian cancer	0.000321	0.00128	CcSEcCtD
Pioglitazone—Nervous system disorder—Docetaxel—ovarian cancer	0.000318	0.00127	CcSEcCtD
Pioglitazone—Infestation NOS—Doxorubicin—ovarian cancer	0.000317	0.00127	CcSEcCtD
Pioglitazone—Infestation—Doxorubicin—ovarian cancer	0.000317	0.00127	CcSEcCtD
Pioglitazone—CYP2D6—female reproductive system—ovarian cancer	0.000317	0.0164	CbGeAlD
Pioglitazone—Feeling abnormal—Paclitaxel—ovarian cancer	0.000315	0.00126	CcSEcCtD
Pioglitazone—Skin disorder—Docetaxel—ovarian cancer	0.000315	0.00126	CcSEcCtD
Pioglitazone—PTGS1—testis—ovarian cancer	0.000312	0.0161	CbGeAlD
Pioglitazone—Urinary tract infection—Doxorubicin—ovarian cancer	0.000309	0.00123	CcSEcCtD
Pioglitazone—Hepatitis—Epirubicin—ovarian cancer	0.000308	0.00123	CcSEcCtD
Pioglitazone—Hypoaesthesia—Epirubicin—ovarian cancer	0.000306	0.00122	CcSEcCtD
Pioglitazone—Pharyngitis—Epirubicin—ovarian cancer	0.000306	0.00122	CcSEcCtD
Pioglitazone—Sweating—Doxorubicin—ovarian cancer	0.000304	0.00122	CcSEcCtD
Pioglitazone—Urinary tract disorder—Epirubicin—ovarian cancer	0.000304	0.00121	CcSEcCtD
Pioglitazone—Urticaria—Paclitaxel—ovarian cancer	0.000304	0.00121	CcSEcCtD
Pioglitazone—Oedema peripheral—Epirubicin—ovarian cancer	0.000303	0.00121	CcSEcCtD
Pioglitazone—Haematuria—Doxorubicin—ovarian cancer	0.000303	0.00121	CcSEcCtD
Pioglitazone—Connective tissue disorder—Epirubicin—ovarian cancer	0.000303	0.00121	CcSEcCtD
Pioglitazone—Urethral disorder—Epirubicin—ovarian cancer	0.000302	0.00121	CcSEcCtD
Pioglitazone—Sinusitis—Doxorubicin—ovarian cancer	0.000298	0.00119	CcSEcCtD
Pioglitazone—Visual impairment—Epirubicin—ovarian cancer	0.000297	0.00119	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000296	0.00118	CcSEcCtD
Pioglitazone—Insomnia—Docetaxel—ovarian cancer	0.000293	0.00117	CcSEcCtD
Pioglitazone—Dyspnoea—Docetaxel—ovarian cancer	0.000289	0.00116	CcSEcCtD
Pioglitazone—CYP2D6—female gonad—ovarian cancer	0.000289	0.0149	CbGeAlD
Pioglitazone—Eye disorder—Epirubicin—ovarian cancer	0.000288	0.00115	CcSEcCtD
Pioglitazone—Cardiac disorder—Epirubicin—ovarian cancer	0.000286	0.00114	CcSEcCtD
Pioglitazone—Hepatitis—Doxorubicin—ovarian cancer	0.000285	0.00114	CcSEcCtD
Pioglitazone—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000284	0.00113	CcSEcCtD
Pioglitazone—Pharyngitis—Doxorubicin—ovarian cancer	0.000283	0.00113	CcSEcCtD
Pioglitazone—Hypersensitivity—Paclitaxel—ovarian cancer	0.000282	0.00113	CcSEcCtD
Pioglitazone—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000281	0.00112	CcSEcCtD
Pioglitazone—Oedema peripheral—Doxorubicin—ovarian cancer	0.000281	0.00112	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.00028	0.00112	CcSEcCtD
Pioglitazone—Connective tissue disorder—Doxorubicin—ovarian cancer	0.00028	0.00112	CcSEcCtD
Pioglitazone—Fatigue—Docetaxel—ovarian cancer	0.00028	0.00112	CcSEcCtD
Pioglitazone—Urethral disorder—Doxorubicin—ovarian cancer	0.000279	0.00112	CcSEcCtD
Pioglitazone—Immune system disorder—Epirubicin—ovarian cancer	0.000278	0.00111	CcSEcCtD
Pioglitazone—Mediastinal disorder—Epirubicin—ovarian cancer	0.000278	0.00111	CcSEcCtD
Pioglitazone—Visual impairment—Doxorubicin—ovarian cancer	0.000275	0.0011	CcSEcCtD
Pioglitazone—Asthenia—Paclitaxel—ovarian cancer	0.000275	0.0011	CcSEcCtD
Pioglitazone—Malnutrition—Epirubicin—ovarian cancer	0.000268	0.00107	CcSEcCtD
Pioglitazone—Feeling abnormal—Docetaxel—ovarian cancer	0.000267	0.00107	CcSEcCtD
Pioglitazone—Eye disorder—Doxorubicin—ovarian cancer	0.000266	0.00106	CcSEcCtD
Pioglitazone—Cardiac disorder—Doxorubicin—ovarian cancer	0.000265	0.00106	CcSEcCtD
Pioglitazone—Flatulence—Epirubicin—ovarian cancer	0.000264	0.00106	CcSEcCtD
Pioglitazone—Diarrhoea—Paclitaxel—ovarian cancer	0.000262	0.00105	CcSEcCtD
Pioglitazone—Back pain—Epirubicin—ovarian cancer	0.000259	0.00104	CcSEcCtD
Pioglitazone—Muscle spasms—Epirubicin—ovarian cancer	0.000258	0.00103	CcSEcCtD
Pioglitazone—Immune system disorder—Doxorubicin—ovarian cancer	0.000257	0.00103	CcSEcCtD
Pioglitazone—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000257	0.00103	CcSEcCtD
Pioglitazone—CYP2D6—testis—ovarian cancer	0.000256	0.0132	CbGeAlD
Pioglitazone—Dizziness—Paclitaxel—ovarian cancer	0.000253	0.00101	CcSEcCtD
Pioglitazone—Ill-defined disorder—Epirubicin—ovarian cancer	0.000249	0.000994	CcSEcCtD
Pioglitazone—Malnutrition—Doxorubicin—ovarian cancer	0.000248	0.000991	CcSEcCtD
Pioglitazone—Anaemia—Epirubicin—ovarian cancer	0.000248	0.00099	CcSEcCtD
Pioglitazone—Flatulence—Doxorubicin—ovarian cancer	0.000244	0.000976	CcSEcCtD
Pioglitazone—Malaise—Epirubicin—ovarian cancer	0.000242	0.000966	CcSEcCtD
Pioglitazone—Vertigo—Epirubicin—ovarian cancer	0.000241	0.000962	CcSEcCtD
Pioglitazone—Back pain—Doxorubicin—ovarian cancer	0.00024	0.000958	CcSEcCtD
Pioglitazone—Headache—Paclitaxel—ovarian cancer	0.00024	0.000958	CcSEcCtD
Pioglitazone—Hypersensitivity—Docetaxel—ovarian cancer	0.000239	0.000955	CcSEcCtD
Pioglitazone—Muscle spasms—Doxorubicin—ovarian cancer	0.000239	0.000953	CcSEcCtD
Pioglitazone—Asthenia—Docetaxel—ovarian cancer	0.000233	0.00093	CcSEcCtD
Pioglitazone—Hypertension—Epirubicin—ovarian cancer	0.000232	0.000925	CcSEcCtD
Pioglitazone—Ill-defined disorder—Doxorubicin—ovarian cancer	0.00023	0.000919	CcSEcCtD
Pioglitazone—Anaemia—Doxorubicin—ovarian cancer	0.000229	0.000916	CcSEcCtD
Pioglitazone—Arthralgia—Epirubicin—ovarian cancer	0.000228	0.000912	CcSEcCtD
Pioglitazone—Myalgia—Epirubicin—ovarian cancer	0.000228	0.000912	CcSEcCtD
Pioglitazone—Chest pain—Epirubicin—ovarian cancer	0.000228	0.000912	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000227	0.000905	CcSEcCtD
Pioglitazone—PTGS1—lymph node—ovarian cancer	0.000226	0.0117	CbGeAlD
Pioglitazone—Discomfort—Epirubicin—ovarian cancer	0.000226	0.000901	CcSEcCtD
Pioglitazone—Malaise—Doxorubicin—ovarian cancer	0.000224	0.000894	CcSEcCtD
Pioglitazone—Vertigo—Doxorubicin—ovarian cancer	0.000223	0.00089	CcSEcCtD
Pioglitazone—Diarrhoea—Docetaxel—ovarian cancer	0.000222	0.000887	CcSEcCtD
Pioglitazone—Anaphylactic shock—Epirubicin—ovarian cancer	0.000219	0.000874	CcSEcCtD
Pioglitazone—Oedema—Epirubicin—ovarian cancer	0.000219	0.000874	CcSEcCtD
Pioglitazone—Infection—Epirubicin—ovarian cancer	0.000217	0.000868	CcSEcCtD
Pioglitazone—Nervous system disorder—Epirubicin—ovarian cancer	0.000215	0.000857	CcSEcCtD
Pioglitazone—Dizziness—Docetaxel—ovarian cancer	0.000215	0.000857	CcSEcCtD
Pioglitazone—Hypertension—Doxorubicin—ovarian cancer	0.000214	0.000855	CcSEcCtD
Pioglitazone—Skin disorder—Epirubicin—ovarian cancer	0.000213	0.000849	CcSEcCtD
Pioglitazone—Hyperhidrosis—Epirubicin—ovarian cancer	0.000212	0.000845	CcSEcCtD
Pioglitazone—Arthralgia—Doxorubicin—ovarian cancer	0.000211	0.000844	CcSEcCtD
Pioglitazone—Chest pain—Doxorubicin—ovarian cancer	0.000211	0.000844	CcSEcCtD
Pioglitazone—Myalgia—Doxorubicin—ovarian cancer	0.000211	0.000844	CcSEcCtD
Pioglitazone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.00021	0.000838	CcSEcCtD
Pioglitazone—Discomfort—Doxorubicin—ovarian cancer	0.000209	0.000833	CcSEcCtD
Pioglitazone—Headache—Docetaxel—ovarian cancer	0.000203	0.000812	CcSEcCtD
Pioglitazone—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000202	0.000809	CcSEcCtD
Pioglitazone—Oedema—Doxorubicin—ovarian cancer	0.000202	0.000809	CcSEcCtD
Pioglitazone—Infection—Doxorubicin—ovarian cancer	0.000201	0.000803	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000199	0.000796	CcSEcCtD
Pioglitazone—Nervous system disorder—Doxorubicin—ovarian cancer	0.000199	0.000793	CcSEcCtD
Pioglitazone—Insomnia—Epirubicin—ovarian cancer	0.000198	0.00079	CcSEcCtD
Pioglitazone—Skin disorder—Doxorubicin—ovarian cancer	0.000197	0.000785	CcSEcCtD
Pioglitazone—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000196	0.000782	CcSEcCtD
Pioglitazone—Dyspnoea—Epirubicin—ovarian cancer	0.000195	0.000779	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000189	0.000755	CcSEcCtD
Pioglitazone—Fatigue—Epirubicin—ovarian cancer	0.000189	0.000754	CcSEcCtD
Pioglitazone—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000184	0.000737	CcSEcCtD
Pioglitazone—Insomnia—Doxorubicin—ovarian cancer	0.000183	0.000731	CcSEcCtD
Pioglitazone—Dyspnoea—Doxorubicin—ovarian cancer	0.000181	0.000721	CcSEcCtD
Pioglitazone—Feeling abnormal—Epirubicin—ovarian cancer	0.00018	0.00072	CcSEcCtD
Pioglitazone—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000175	0.000698	CcSEcCtD
Pioglitazone—Fatigue—Doxorubicin—ovarian cancer	0.000175	0.000697	CcSEcCtD
Pioglitazone—Urticaria—Epirubicin—ovarian cancer	0.000174	0.000694	CcSEcCtD
Pioglitazone—Feeling abnormal—Doxorubicin—ovarian cancer	0.000167	0.000666	CcSEcCtD
Pioglitazone—Hypersensitivity—Epirubicin—ovarian cancer	0.000161	0.000644	CcSEcCtD
Pioglitazone—Urticaria—Doxorubicin—ovarian cancer	0.000161	0.000642	CcSEcCtD
Pioglitazone—Asthenia—Epirubicin—ovarian cancer	0.000157	0.000627	CcSEcCtD
Pioglitazone—Diarrhoea—Epirubicin—ovarian cancer	0.00015	0.000598	CcSEcCtD
Pioglitazone—Hypersensitivity—Doxorubicin—ovarian cancer	0.000149	0.000596	CcSEcCtD
Pioglitazone—Asthenia—Doxorubicin—ovarian cancer	0.000145	0.00058	CcSEcCtD
Pioglitazone—Dizziness—Epirubicin—ovarian cancer	0.000145	0.000578	CcSEcCtD
Pioglitazone—Diarrhoea—Doxorubicin—ovarian cancer	0.000139	0.000553	CcSEcCtD
Pioglitazone—Headache—Epirubicin—ovarian cancer	0.000137	0.000548	CcSEcCtD
Pioglitazone—Dizziness—Doxorubicin—ovarian cancer	0.000134	0.000535	CcSEcCtD
Pioglitazone—Headache—Doxorubicin—ovarian cancer	0.000127	0.000507	CcSEcCtD
Pioglitazone—SLCO1B1—Metabolism—CYTB—ovarian cancer	5.68e-05	0.00117	CbGpPWpGaD
Pioglitazone—PPARG—Adipogenesis—IL6—ovarian cancer	5.64e-05	0.00116	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.55e-05	0.00114	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.5e-05	0.00113	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—YAP1—ovarian cancer	5.44e-05	0.00112	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	5.42e-05	0.00112	CbGpPWpGaD
Pioglitazone—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	5.4e-05	0.00111	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	5.38e-05	0.00111	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—ESR1—ovarian cancer	5.26e-05	0.00108	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.21e-05	0.00107	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—NME2—ovarian cancer	5.06e-05	0.00104	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYTB—ovarian cancer	5.05e-05	0.00104	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MET—ovarian cancer	4.98e-05	0.00103	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPP1CC—ovarian cancer	4.96e-05	0.00102	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—BRIP1—ovarian cancer	4.96e-05	0.00102	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—YAP1—ovarian cancer	4.95e-05	0.00102	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.94e-05	0.00102	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.9e-05	0.00101	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6ST—ovarian cancer	4.87e-05	0.001	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—PGR—ovarian cancer	4.75e-05	0.000978	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.59e-05	0.000946	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—NME2—ovarian cancer	4.52e-05	0.000931	CbGpPWpGaD
Pioglitazone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.46e-05	0.000918	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPP1CC—ovarian cancer	4.41e-05	0.00091	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—BRIP1—ovarian cancer	4.41e-05	0.00091	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—PARP1—ovarian cancer	4.41e-05	0.000909	CbGpPWpGaD
Pioglitazone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.4e-05	0.000906	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—TP53—ovarian cancer	4.35e-05	0.000895	CbGpPWpGaD
Pioglitazone—SLCO1B1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.34e-05	0.000895	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	4.31e-05	0.000888	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.29e-05	0.000885	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—YAP1—ovarian cancer	4.23e-05	0.000871	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	4.18e-05	0.000862	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—NME2—ovarian cancer	4.16e-05	0.000856	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MMP2—ovarian cancer	4.15e-05	0.000855	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—NME2—ovarian cancer	4.12e-05	0.000849	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—FASN—ovarian cancer	4.04e-05	0.000832	CbGpPWpGaD
Pioglitazone—PPARG—Circadian rythm related genes—IL6—ovarian cancer	3.98e-05	0.00082	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—SLC5A5—ovarian cancer	3.97e-05	0.000818	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—SLC2A1—ovarian cancer	3.84e-05	0.00079	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.83e-05	0.00079	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.76e-05	0.000774	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CYP1B1—ovarian cancer	3.68e-05	0.000758	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.68e-05	0.000758	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—ERBB2—ovarian cancer	3.64e-05	0.000749	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.62e-05	0.000745	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—PPP2R1A—ovarian cancer	3.58e-05	0.000738	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.5e-05	0.000721	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.5e-05	0.00072	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—FASN—ovarian cancer	3.45e-05	0.00071	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—SLC5A5—ovarian cancer	3.39e-05	0.000698	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—YAP1—ovarian cancer	3.33e-05	0.000686	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.29e-05	0.000679	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—SLC2A1—ovarian cancer	3.27e-05	0.000674	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYTB—ovarian cancer	3.26e-05	0.000672	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PPP2R1A—ovarian cancer	3.26e-05	0.000672	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	3.25e-05	0.000669	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.22e-05	0.000663	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	3.21e-05	0.00066	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.19e-05	0.000657	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—CTNNB1—ovarian cancer	3.18e-05	0.000656	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CYP1B1—ovarian cancer	3.14e-05	0.000647	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.12e-05	0.000644	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MMP9—ovarian cancer	3.12e-05	0.000643	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—ABCB1—ovarian cancer	3.03e-05	0.000624	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—TYMS—ovarian cancer	2.97e-05	0.000613	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—YAP1—ovarian cancer	2.96e-05	0.00061	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.93e-05	0.000604	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYTB—ovarian cancer	2.91e-05	0.0006	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.9e-05	0.000597	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPP1CC—ovarian cancer	2.85e-05	0.000588	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—BRIP1—ovarian cancer	2.85e-05	0.000588	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.85e-05	0.000587	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.85e-05	0.000586	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—VEGFA—ovarian cancer	2.8e-05	0.000577	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PPP2R1A—ovarian cancer	2.78e-05	0.000573	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—STAT3—ovarian cancer	2.77e-05	0.000571	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.77e-05	0.000571	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—NRAS—ovarian cancer	2.77e-05	0.00057	CbGpPWpGaD
Pioglitazone—PPARG—Generic Transcription Pathway—MYC—ovarian cancer	2.74e-05	0.000564	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—NME2—ovarian cancer	2.72e-05	0.00056	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—FASN—ovarian cancer	2.71e-05	0.000559	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYTB—ovarian cancer	2.68e-05	0.000552	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SLC5A5—ovarian cancer	2.67e-05	0.00055	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYTB—ovarian cancer	2.66e-05	0.000547	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MAPK3—ovarian cancer	2.65e-05	0.000546	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.59e-05	0.000535	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—ABCB1—ovarian cancer	2.58e-05	0.000532	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—SLC2A1—ovarian cancer	2.58e-05	0.000531	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.58e-05	0.000531	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPP1CC—ovarian cancer	2.55e-05	0.000524	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—BRIP1—ovarian cancer	2.55e-05	0.000524	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—TYMS—ovarian cancer	2.54e-05	0.000523	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—ESR1—ovarian cancer	2.53e-05	0.000522	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.52e-05	0.00052	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—MAPK1—ovarian cancer	2.52e-05	0.00052	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—EGFR—ovarian cancer	2.52e-05	0.000519	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CYP1B1—ovarian cancer	2.47e-05	0.000509	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—FASN—ovarian cancer	2.41e-05	0.000497	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—CAV1—ovarian cancer	2.4e-05	0.000494	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—KRAS—ovarian cancer	2.38e-05	0.000491	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SLC5A5—ovarian cancer	2.37e-05	0.000489	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPP1CC—ovarian cancer	2.34e-05	0.000482	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—BRIP1—ovarian cancer	2.34e-05	0.000482	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—BRIP1—ovarian cancer	2.32e-05	0.000478	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPP1CC—ovarian cancer	2.32e-05	0.000478	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—SLC2A1—ovarian cancer	2.29e-05	0.000472	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	2.29e-05	0.000472	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.25e-05	0.000463	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CYP1B1—ovarian cancer	2.2e-05	0.000453	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PPP2R1A—ovarian cancer	2.19e-05	0.000452	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CG—ovarian cancer	2.18e-05	0.00045	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.18e-05	0.000449	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.08e-05	0.000428	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—CAV1—ovarian cancer	2.05e-05	0.000421	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—ABCB1—ovarian cancer	2.03e-05	0.000419	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—HRAS—ovarian cancer	2.02e-05	0.000417	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—TYMS—ovarian cancer	2e-05	0.000412	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.95e-05	0.000403	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PPP2R1A—ovarian cancer	1.95e-05	0.000402	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.94e-05	0.0004	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—IL6—ovarian cancer	1.94e-05	0.000399	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CD—ovarian cancer	1.92e-05	0.000395	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—YAP1—ovarian cancer	1.91e-05	0.000394	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.89e-05	0.00039	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CG—ovarian cancer	1.86e-05	0.000384	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.85e-05	0.000382	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—ABCB1—ovarian cancer	1.81e-05	0.000373	CbGpPWpGaD
Pioglitazone—PPARG—Developmental Biology—AKT1—ovarian cancer	1.79e-05	0.000368	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—TYMS—ovarian cancer	1.78e-05	0.000366	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYTB—ovarian cancer	1.75e-05	0.000361	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—YAP1—ovarian cancer	1.71e-05	0.000352	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.69e-05	0.000348	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.69e-05	0.000348	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CB—ovarian cancer	1.67e-05	0.000345	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.66e-05	0.000343	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CD—ovarian cancer	1.64e-05	0.000337	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—CAV1—ovarian cancer	1.61e-05	0.000332	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—YAP1—ovarian cancer	1.57e-05	0.000324	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—FASN—ovarian cancer	1.56e-05	0.000321	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—YAP1—ovarian cancer	1.56e-05	0.000321	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.54e-05	0.000317	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.54e-05	0.000317	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.53e-05	0.000316	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.53e-05	0.000315	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.53e-05	0.000315	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.49e-05	0.000306	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—SLC2A1—ovarian cancer	1.48e-05	0.000305	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CG—ovarian cancer	1.47e-05	0.000302	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.45e-05	0.000299	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PTEN—ovarian cancer	1.45e-05	0.000298	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—CAV1—ovarian cancer	1.43e-05	0.000295	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CB—ovarian cancer	1.43e-05	0.000294	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CYP1B1—ovarian cancer	1.42e-05	0.000293	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—FASN—ovarian cancer	1.39e-05	0.000287	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC5A5—ovarian cancer	1.37e-05	0.000282	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.37e-05	0.000282	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MAPK3—ovarian cancer	1.36e-05	0.000279	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.35e-05	0.000279	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—SLC2A1—ovarian cancer	1.32e-05	0.000272	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—MYC—ovarian cancer	1.32e-05	0.000272	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CG—ovarian cancer	1.3e-05	0.000269	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.29e-05	0.000267	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CD—ovarian cancer	1.29e-05	0.000266	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—FASN—ovarian cancer	1.28e-05	0.000264	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—FASN—ovarian cancer	1.27e-05	0.000261	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CYP1B1—ovarian cancer	1.27e-05	0.000261	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	1.26e-05	0.000259	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC5A5—ovarian cancer	1.26e-05	0.000259	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.25e-05	0.000258	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC5A5—ovarian cancer	1.25e-05	0.000257	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PTEN—ovarian cancer	1.23e-05	0.000254	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—SLC2A1—ovarian cancer	1.22e-05	0.000251	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—SLC2A1—ovarian cancer	1.21e-05	0.000248	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.18e-05	0.000243	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—ABCB1—ovarian cancer	1.17e-05	0.000241	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CYP1B1—ovarian cancer	1.17e-05	0.00024	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CYP1B1—ovarian cancer	1.16e-05	0.000238	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—TYMS—ovarian cancer	1.15e-05	0.000237	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CD—ovarian cancer	1.15e-05	0.000236	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	1.12e-05	0.000232	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CB—ovarian cancer	1.12e-05	0.000232	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.12e-05	0.00023	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—ABCB1—ovarian cancer	1.04e-05	0.000215	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PPP2R1A—ovarian cancer	1.03e-05	0.000213	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—YAP1—ovarian cancer	1.03e-05	0.000212	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—TYMS—ovarian cancer	1.03e-05	0.000211	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	1.02e-05	0.000211	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.02e-05	0.00021	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—PIK3CA—ovarian cancer	1.02e-05	0.00021	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CB—ovarian cancer	1e-05	0.000206	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PTEN—ovarian cancer	9.71e-06	0.0002	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—ABCB1—ovarian cancer	9.6e-06	0.000198	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—ABCB1—ovarian cancer	9.52e-06	0.000196	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—TYMS—ovarian cancer	9.43e-06	0.000194	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—TYMS—ovarian cancer	9.35e-06	0.000193	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—CAV1—ovarian cancer	9.25e-06	0.000191	CbGpPWpGaD
Pioglitazone—PPARG—Gene Expression—AKT1—ovarian cancer	9.14e-06	0.000188	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.84e-06	0.000182	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—PIK3CA—ovarian cancer	8.7e-06	0.000179	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PTEN—ovarian cancer	8.64e-06	0.000178	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CG—ovarian cancer	8.43e-06	0.000174	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—FASN—ovarian cancer	8.37e-06	0.000172	CbGpPWpGaD
Pioglitazone—SLCO1B3—Metabolism—AKT1—ovarian cancer	8.33e-06	0.000172	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—CAV1—ovarian cancer	8.26e-06	0.00017	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	8.23e-06	0.00017	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	7.95e-06	0.000164	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.89e-06	0.000163	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	7.62e-06	0.000157	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—CAV1—ovarian cancer	7.6e-06	0.000157	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—CAV1—ovarian cancer	7.53e-06	0.000155	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CG—ovarian cancer	7.52e-06	0.000155	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CD—ovarian cancer	7.41e-06	0.000153	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.2e-06	0.000148	CbGpPWpGaD
Pioglitazone—PPARG—Metabolism—AKT1—ovarian cancer	7.11e-06	0.000146	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CG—ovarian cancer	6.92e-06	0.000143	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CG—ovarian cancer	6.86e-06	0.000141	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—PIK3CA—ovarian cancer	6.85e-06	0.000141	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.76e-06	0.000139	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CD—ovarian cancer	6.61e-06	0.000136	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CB—ovarian cancer	6.46e-06	0.000133	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—ABCB1—ovarian cancer	6.28e-06	0.000129	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—TYMS—ovarian cancer	6.16e-06	0.000127	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—PIK3CA—ovarian cancer	6.1e-06	0.000126	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CD—ovarian cancer	6.08e-06	0.000125	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CD—ovarian cancer	6.03e-06	0.000124	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CB—ovarian cancer	5.77e-06	0.000119	CbGpPWpGaD
Pioglitazone—SLCO1B1—Metabolism—AKT1—ovarian cancer	5.6e-06	0.000115	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PTEN—ovarian cancer	5.58e-06	0.000115	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CB—ovarian cancer	5.3e-06	0.000109	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CB—ovarian cancer	5.26e-06	0.000108	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PTEN—ovarian cancer	4.98e-06	0.000103	CbGpPWpGaD
Pioglitazone—PTGS1—Metabolism—AKT1—ovarian cancer	4.98e-06	0.000103	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—CAV1—ovarian cancer	4.97e-06	0.000102	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PTEN—ovarian cancer	4.58e-06	9.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PTEN—ovarian cancer	4.54e-06	9.36e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.52e-06	9.32e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.98e-06	8.2e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—PIK3CA—ovarian cancer	3.94e-06	8.11e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—PIK3CA—ovarian cancer	3.51e-06	7.24e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.47e-06	7.14e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—PIK3CA—ovarian cancer	3.23e-06	6.66e-05	CbGpPWpGaD
Pioglitazone—CYP2C8—Metabolism—AKT1—ovarian cancer	3.22e-06	6.63e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—PIK3CA—ovarian cancer	3.2e-06	6.6e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PTEN—ovarian cancer	3e-06	6.17e-05	CbGpPWpGaD
Pioglitazone—CYP2C19—Metabolism—AKT1—ovarian cancer	2.87e-06	5.92e-05	CbGpPWpGaD
Pioglitazone—CYP2D6—Metabolism—AKT1—ovarian cancer	2.64e-06	5.44e-05	CbGpPWpGaD
Pioglitazone—CYP2C9—Metabolism—AKT1—ovarian cancer	2.62e-06	5.39e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.11e-06	4.35e-05	CbGpPWpGaD
Pioglitazone—CYP3A4—Metabolism—AKT1—ovarian cancer	1.73e-06	3.56e-05	CbGpPWpGaD
